These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 2764537)
21. Entry of four cephalosporins into the ovine lung. Cohen SH; Hoeprich PD; Demling R; Gunther R; Merry JM; Franti CE; Miner DJ J Infect Dis; 1984 Feb; 149(2):264-70. PubMed ID: 6321609 [TBL] [Abstract][Full Text] [Related]
22. Effects of beta-lactam antibiotics and N-methyltetrazolethiol on the alcohol-metabolizing system in rats. Matsubara T; Otsubo S; Ogawa A; Kawamoto K; Okamoto J; Sugeno K; Tochino Y; Yoshida T; Hirai E Jpn J Pharmacol; 1987 Nov; 45(3):303-15. PubMed ID: 2893854 [TBL] [Abstract][Full Text] [Related]
23. Effects of a vitamin K-deficient diet and antibiotics in normal human volunteers. Allison PM; Mummah-Schendel LL; Kindberg CG; Harms CS; Bang NU; Suttie JW J Lab Clin Med; 1987 Aug; 110(2):180-8. PubMed ID: 3598347 [TBL] [Abstract][Full Text] [Related]
24. A review and summary of the pharmacokinetics of cefoperazone: a new, extended-spectrum beta-lactam antibiotic. Neu HC Ther Drug Monit; 1981; 3(2):121-8. PubMed ID: 6455787 [TBL] [Abstract][Full Text] [Related]
25. [A study of prostatic tissue levels of latamoxef, cefoperazone and cefotaxime]. Takeuchi N; Kinukawa T; Matsuura O; Hattori R; Hasegawa S; Ohshima S; Ono Y Hinyokika Kiyo; 1986 Dec; 32(12):1831-41. PubMed ID: 2435132 [TBL] [Abstract][Full Text] [Related]
26. Comparison of interactions between warfarin and cephalosporins with and without the N-methyl-thio-tetrazole side chain. Imai S; Kadomura S; Momo K; Kashiwagi H; Sato Y; Miyai T; Sugawara M; Takekuma Y J Infect Chemother; 2020 Nov; 26(11):1224-1228. PubMed ID: 32800690 [TBL] [Abstract][Full Text] [Related]
27. Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa. Corrado ML; Landesman SH; Cherubin CE Antimicrob Agents Chemother; 1980 Dec; 18(6):893-6. PubMed ID: 6263178 [TBL] [Abstract][Full Text] [Related]
28. Susceptibility of bacterial pathogens to cefotetan judged by MIC and disc tests. Grimm H J Antimicrob Chemother; 1983 Jan; 11 Suppl():37-43. PubMed ID: 6573324 [TBL] [Abstract][Full Text] [Related]
29. [Free methyltetrazolethiol concentrations in men subjected to intravenous administration of cephems with methyltetrazolethiol]. Nakahata H; Hirai Y; Kumasaka Y; Miyazawa T; Nakamura T; Imamura K; Makino I; Takebe K; Kudo H Jpn J Antibiot; 1987 Jul; 40(7):1294-8. PubMed ID: 3479623 [TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of cefotetan (YM09330) in humans. Nakagawa K; Koyama M; Tachibana A; Komiya M; Kikuchi Y; Yano K Antimicrob Agents Chemother; 1982 Dec; 22(6):935-41. PubMed ID: 6961888 [TBL] [Abstract][Full Text] [Related]
31. Integration of selected pharmacologic and microbiologic properties of three new beta-lactam antibiotics: a hypothesis for rational comparison. Drusano GL; Ryan PA; Standiford HC; Moody MR; Schimpff SC Rev Infect Dis; 1984; 6(3):357-63. PubMed ID: 6330835 [TBL] [Abstract][Full Text] [Related]
32. In vitro activity of moxalactam and cefoperazone against Streptococcus pneumoniae with differing susceptibilities to penicillin. Tarpay MM; Welch DF; Marks MI Chemotherapy; 1982; 28(4):261-6. PubMed ID: 6214382 [TBL] [Abstract][Full Text] [Related]
33. Comparative pharmacokinetics of ceftazidime and moxalactam. Tjandramaga TB; Van Hecken A; Mullie A; Verbesselt R; De Schepper PJ; Verbist L Antimicrob Agents Chemother; 1982 Aug; 22(2):237-41. PubMed ID: 6765416 [TBL] [Abstract][Full Text] [Related]
34. Activity and specific beta-lactamase susceptibility of cefoperazone and moxalactam. Comparison with other cephalosporins. Mouton RP; Bongaerts GP; van Gestel M; Bruggeman-Ogle KM Chemotherapy; 1981; 27(5):318-24. PubMed ID: 6455258 [TBL] [Abstract][Full Text] [Related]
35. Multicenter clinical trials comparing cefotetan with moxalactam or cefoxitin as therapy for obstetric and gynecologic infections. Sweet RL; Gall SA; Gibbs RS; Hemsell DL; Knuppel RA; Lane TW; Miller RD; Newton ER; Poindexter AN; Reguero W Am J Surg; 1988 May; 155(5A):56-60. PubMed ID: 3287970 [TBL] [Abstract][Full Text] [Related]
36. Cefotetan pharmacokinetics in volunteers with various degrees of renal function. Smith BR; LeFrock JL; Thyrum PT; Doret BA; Yeh C; Onesti G; Schwartz A; Zimmerman JJ Antimicrob Agents Chemother; 1986 May; 29(5):887-93. PubMed ID: 3460524 [TBL] [Abstract][Full Text] [Related]
37. Cephalosporin therapy in intraabdominal infections. A multicenter randomized, comparative study of cefotetan, moxalactam, and cefoxitin. Wilson SE; Boswick JA; Duma RJ; Echols RM; Jemsek JG; Lerner R; Lewis RT; Najem AZ; Press RA; Rittenbury MS Am J Surg; 1988 May; 155(5A):61-6. PubMed ID: 3287971 [TBL] [Abstract][Full Text] [Related]
38. N-methyl-thio-tetrazole inhibition of the gamma carboxylation of glutamic acid: possible mechanism for antibiotic-associated hypoprothrombinaemia. Lipsky JJ Lancet; 1983 Jul; 2(8343):192-3. PubMed ID: 6135030 [TBL] [Abstract][Full Text] [Related]
39. Penetration of latamoxef, cefoperazone and piperacillin into the sputum of patients with cystic fibrosis. Laferriere C; Stutman HR; Marks MI; Kramer J; Flux M Chemotherapy; 1985; 31(4):255-60. PubMed ID: 3928280 [TBL] [Abstract][Full Text] [Related]
40. Absolute bioavailability and noncompartmental analysis of intravenous and intramuscular Cefotan (cefotetan) in normal volunteers. Zimmerman J; Cohen A; Thyrum P J Clin Pharmacol; 1989 Feb; 29(2):151-7. PubMed ID: 2715372 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]